Malignant Phyllodes Tumors: Diagnostic, Investigative and Therapeutic Challenges

Phyllodes tumors are rare fibroepithelial neoplasms of the breast, and their malignant forms present significant diagnostic and therapeutic challenges. This review summarizes current knowledge across the benign-to-malignant spectrum, focusing on diagnostic approaches, histopathological classification, molecular alterations, and treatment strategies. While recent molecular studies have revealed recurrent genetic mutations, their clinical implications remain under investigation. Surgical excision remains the cornerstone of treatment, and systemic therapies are generally adapted from soft tissue sarcoma protocols. Future efforts should focus on improving diagnostic accuracy, identifying molecular targets for therapy, and fostering international collaboration to advance clinical research in this rare tumor type.

Authors

Institutions

Publication Details

Journal
Encyclopedia
Published
2025-10-02
DOI
https://doi.org/10.3390/encyclopedia5040157
Citations
2
Primary Topic
Breast Lesions and Carcinomas
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Malignant Phyllodes Tumors: Diagnostic, Investigative and Therapeutic Challenges

Manabu Seino, Masaaki Kawai, Hidenori Sato, Koshi Takahashi et al.
2 citations
Encyclopedia
Breast Lesions and Carcinomas
2.94
article

Malignant Phyllodes Tumors: Diagnostic, Investigative and Therapeutic Challenges

Manabu Seino, Masaaki Kawai, Hidenori Sato, Koshi Takahashi, Yuta Yamada, Ryosuke Kumanishi, Yosuke Saito, Koki Saito, Tadahisa Fukui, Shuhei Suzuki
article en
2 citations

Abstract

Phyllodes tumors are rare fibroepithelial neoplasms of the breast, and their malignant forms present significant diagnostic and therapeutic challenges. This review summarizes current knowledge across the benign-to-malignant spectrum, focusing on diagnostic approaches, histopathological classification, molecular alterations, and treatment strategies. While recent molecular studies have revealed recurrent genetic mutations, their clinical implications remain under investigation. Surgical excision remains the cornerstone of treatment, and systemic therapies are generally adapted from soft tissue sarcoma protocols. Future efforts should focus on improving diagnostic accuracy, identifying molecular targets for therapy, and fostering international collaboration to advance clinical research in this rare tumor type.

EncyclopediaVol. 5(4)
Yamagata University (JP)
Openalex Percentile: Top 8%
Breast Lesions and Carcinomas
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.